Tue, May 31, 2011
Mon, May 30, 2011
Fri, May 27, 2011
Thu, May 26, 2011
Wed, May 25, 2011
Tue, May 24, 2011
Mon, May 23, 2011
Sun, May 22, 2011
Fri, May 20, 2011
Thu, May 19, 2011
Wed, May 18, 2011
Tue, May 17, 2011
Mon, May 16, 2011
Sun, May 15, 2011
[ Sun, May 15th 2011 ] - Market Wire
Teva to Acquire Taiyo
Fri, May 13, 2011
Thu, May 12, 2011
Wed, May 11, 2011
Tue, May 10, 2011
Mon, May 9, 2011
Sun, May 8, 2011
Sat, May 7, 2011
Fri, May 6, 2011
Thu, May 5, 2011
Wed, May 4, 2011
Tue, May 3, 2011
Mon, May 2, 2011
Fri, April 29, 2011
Thu, April 28, 2011

The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Orthov


//health-fitness.news-articles.net/content/2011/ .. es-of-fiduciary-duty-by-the-board-of-orthov.html
Published in Health and Fitness on Monday, May 16th 2011 at 9:30 GMT by Market Wire   Print publication without navigation


NEW YORK--([ BUSINESS WIRE ])--Levi & Korsinsky is investigating the Board of Directors of Orthovita, Inc. (aOrthovitaa or the aCompanya) (Nasdaq: VITA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Stryker Corporation (NYSE: SYK). Under the terms of the transaction, Orthovita shareholders will receive $3.85 for each outstanding Orthovita share they own. The transaction has a total value of approximately $316 million.

Click here to learn how to join the action: [ http://www.zlk.com/orthovita-vita.html ], or call: 877-363-5972.

The investigation concerns whether the Orthovita Board of Directors breached their fiduciary duties to Orthovita stockholders by failing to adequately shop the Company before entering into this transaction and whether Stryker Corporation is underpaying for Orthovita shares, thus unlawfully harming Orthovita stockholders. In particular, at least one analyst set a price target for Orthovita stock at $4.00 per share.

If you own common stock in Orthovita and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit [ http://www.zlk.com/orthovita-vita.html ].

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.


Publication Contributing Sources